ArticleCureus2026
Acute-Onset Type 1 Diabetes in a Patient With Autoimmune Polyendocrine Syndrome Type 3A Following Influenza A Infection: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type 1 diabetes is characterized by autoimmune destruction of pancreatic β-cells, driven by a combination of genetic susceptibility and environmental triggers. Influenza A virus infection has been reported to increase the risk of developing type 1 diabetes. A 63-year-old Japanese woman with underlying Hashimoto's disease contracted influenza one month prior. After contracting influenza A, she experienced persistent dry mouth and fatigue and presented to our outpatient clinic. She was diagnosed with diabetic ketoacidosis (DKA) caused by acute-onset type 1 diabetes. Given the coexistence of Hashimoto's thyroiditis, she was diagnosed with autoimmune polyendocrine syndrome (APS) type 3A. DKA resolved with intravenous insulin and fluid therapy, and the patient was discharged on a basal-bolus insulin regimen. Clinicians should consider the possibility of type 1 diabetes in patients with autoimmune thyroid disease who develop hyperglycemic symptoms, such as polydipsia, polyuria, or weight loss, following influenza infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.